598 % for plain glutathione
According to a 2024 review, There were no serious adverse events attributed directly to [urolithin A] reported in any of the studies
Acetyl-L-carnitine in chronic pain: a narrative review
These models were fitted separately for each of the data sources (ie, CDM, MarketScan, and Medicare) and for each drug comparison (SGLT-2 inhibitors v DPP-4 inhibitors, GLP-1 receptor agonists v DPP-4 inhibitors, and SGLT-2 inhibitors v GLP-1 receptor agonists), for a total of nine propensity score models
They range from 250 to 1500 g for BPC-157 in most studies, and from 50 to 1000mcg for TB-500
84% were white, 9% were Black/African American, and 7% were Hispanic